InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: heartofwolf post# 296566

Tuesday, 05/09/2017 7:48:55 AM

Tuesday, May 09, 2017 7:48:55 AM

Post# of 346050
heartowolf, that information is incorrect and it can be proven.

There is a PPHM PR or Q/CC or Annual report (I am not sure which) in which PPHM literally says that the Sunrise participants (clinical trial centres and their lead investigators) volunteered for other clinical trials with Bavituximab given the good results they have.

And that statement will pass the Lacquer test because we KNOW that the Bavituximab arm had very good results in Sunrise.

A Doctor in a hospital doesn't compare ARMS because he is not aware of who is in what arm. He compares results of his daily practice and then sees that people in the Sunrise trial live much longer.

The doctor, during that observation, is NOT POLLUTED by 3rd line interference because he sees the results BEFORE. That is... he sees patients survive and slowed down progress as reported in the Sunrise results even before they had a 3rd line treatment and compares that with his patients that he treated in the past and that NEVER achieve those results.

The control arm is an FDA thing, if it has abnormal results as was the case in Sunrise (it dramatically outperformed) then the drug under investigation may outperform itself but that will never create the needed difference in progress as defined in the end-points.

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News